Pulmonary vascular clearance of harmful endogenous macromolecules in a porcine model of acute liver failure

Autor: Kjetil Elvevold, Bård Smedsrød, Lars M. Ytrebø, Marcio F. Chedid, Rajiv Jalan, Arthur Revhaug, Geir I. Nedredal, Sambit Sen, Christopher F. Rose
Jazyk: angličtina
Rok vydání: 2016
Předmět:
0301 basic medicine
medicine.medical_specialty
Pathology
Time Factors
Hyaluronic acid
Sus scrofa
Specialties of internal medicine
Tissue plasminogen activator
03 medical and health sciences
Liver disease
chemistry.chemical_compound
0302 clinical medicine
Internal medicine
Macrophages
Alveolar

medicine
Animals
Liver sinusoidal endothelial cells
Receptor
Lung
Serum Albumin
Pulmonary intravascular macrophages
Leukopenia
Hepatology
business.industry
Albumin
Endothelial Cells
Biological Transport
Lung Injury
General Medicine
Liver Failure
Acute

medicine.disease
Systemic inflammatory response syndrome
Disease Models
Animal

030104 developmental biology
Endocrinology
medicine.anatomical_structure
chemistry
RC581-951
030211 gastroenterology & hepatology
Tumor necrosis factor alpha
Inflammation Mediators
medicine.symptom
business
Fluorescein-5-isothiocyanate
medicine.drug
Zdroj: Annals of Hepatology, Vol 15, Iss 3, Pp 427-435 (2016)
ISSN: 1665-2681
Popis: Background. Pulmonary complications are common in acute liver failure (ALF). The role of the lungs in the uptake of harmful soluble endogenous macromolecules was evaluated in a porcine model of ALF induced by hepatic devascularization (n = 8) vs. controls (n = 8). In additional experiments, pulmonary uptake was investigated in healthy pigs. Fluorochrome-labeled modified albumin (MA) was applied to investigate the cellular uptake. Results. As compared to controls, the ALF group displayed a 4-fold net increased lung uptake of hyaluronan, and 5-fold net increased uptake of both tissue plasminogen activator and lysosomal enzymes. Anatomical distribution experiments in healthy animals revealed that radiolabeled MA uptake (taken up by the same receptor as hyaluronan) was 53% by the liver, and 24% by the lungs. The lung uptake of LPS was 14% whereas 60% remained in the blood. Both fluorescence and electron microscopy revealed initial uptake of MA by pulmonary endothelial cells (PECs) with later translocation to pulmonary intravascular macrophages (PIMs). Moreover, the presence of PIMs was evident 10 min after injection. Systemic inflammatory markers such as leukopenia and increased serum TNF-α levels were evident after 20 min in the MA and LPS groups. Conclusion. Significant lung uptake of harmful soluble macromolecules compensated for the defect liver scavenger function in the ALF-group. Infusion of MA induced increased TNF-α serum levels and leukopenia, similar to the effect of the known inflammatory mediator LPS. These observations suggest a potential mechanism that may contribute to lung damage secondary to liver disease.
Databáze: OpenAIRE